Filing Flows › Milestone Scientific (MLSS) › Q1 2026 › vs Q1 2025
Milestone Scientific (MLSS) Q1 2026 vs Q1 2025 (year over year)
Milestone Scientific's revenue fell $70K (-3%) from $2.2M in Q1 2025 to $2.2M in Q1 2026.
Milestone Scientific, Q1 2026: revenue $2.2M (-3% year over year), operating margin -38.3%, net loss $840K, operating cash flow $87K. The chart draws each line against Q1 2025, the increases inside each band.
Margins
| Q1 2026 | Q1 2025 | Change | |
|---|---|---|---|
| Free cash flow margin | 3.9% | -45.2% | +49.2 pts |
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $2.2M | $2.2M | −$70K | -3% |
| Net loss | $840K | $2.0M | −$1.2M | -58% |
| Costs & expenses | $3.0M | $4.2M | −$1.2M | -29% |
| Operating costs | $3.0M | $4.2M | −$1.2M | -29% |
| Interest & other, net | $12K | −$3K | $15K | — |
| Cost of revenue | $598K | $585K | $13K | +2% |
| SG&A | $2.4M | $3.3M | −$884K | -27% |
| Other operating costs | $19K | $19K | $14 | +0.1% |
| Operating cash sources | $927K | $986K | −$60K | -6% |
| Depreciation & amortization | $19K | $19K | $14 | +0.1% |
| Share-based compensation | $257K | $331K | −$74K | -22% |
| Working capital & other | $651K | $636K | $14K | +2% |
| Net loss absorbed | $840K | $2.0M | −$1.2M | -58% |
| Operating cash flow | $87K | −$1.0M | $1.1M | — |
| Free cash flow (OCF − capex) | $85K | −$1.0M | $1.1M | — |
| Capital expenditures | $2K | $1K | $328 | +25% |
Questions
How much did Milestone Scientific's revenue grow year over year in Q1 2026?
Milestone Scientific's revenue fell $70K (-3%) from $2.2M in Q1 2025 to $2.2M in Q1 2026.